IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN COLOMBIA

被引：0
|
作者：
Lopez-Cabra, C. [1 ]
Rodriguez, A. D. [2 ]
Mayorga, Mogollon W. [2 ]
Zuluaga, J. R. [3 ]
Patino, A. [1 ]
Herran, S. E. [3 ]
Marrugo, R. [3 ]
机构：
[1] Bayer, Bogota, Cun, Colombia
[2] Numeris, Bogota, Colombia
[3] Bayer, Bogota, Colombia
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE425
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Finerenone in Patients with CKD and T2D by Baseline Insulin Treatment
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Macisaac, Richard
    Wainstein, Julio
    Joseph, Amer
    Roessig, Lothar
    Scott, Charlie
    Bakris, George
    DIABETES, 2021, 70
  • [32] Chronic kidney disease (CKD) in US adults with type 2 diabetes (T2D) and/or cardiovascular diseases (CVD): A national estimate of prevalence by KDIGO 2012 classification
    Wang, Tongtong
    Xi, Yuzhi
    Lubwama, Robert
    Koro, Carol
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 84 - 84
  • [33] FINERENONE ADDED TO TREATMENT GUIDELINES FOR TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2023, 123 (05) : 23 - 23
  • [34] In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes
    Mayne, Kaitlin J.
    Herrington, William G.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (05) : JC54 - JC54
  • [35] Effect of Sotagliflozin (SOTA) on Albuminuria in Patients With Type 2 Diabetes (T2D) and CKD
    Cherney, David
    Bhatt, Deepak L.
    Szarek, Michael
    Sun, Franklin W.
    Davies, Michael J.
    Pitt, Bertram
    Steg, Philippe Gabriel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 675 - 675
  • [36] Distance to Glycemic Target of Patients (Pts) with Type 2 Diabetes (T2D) and Established Cardiovascular Disease (eCVD) and/or Chronic Kidney Disease (CKD) Failing Metformin Monotherapy in the US
    Fernandes, Gail
    Sawhney, Baanie
    Hannachi, Hakima
    Wang, Tongtong
    Mcneill, Ann Marie
    DIABETES, 2019, 68
  • [37] Inside CKD: modelling the future global burden of chronic kidney disease in patients with type 2 diabetes
    Tangri, N.
    Arnlov, J.
    Batista, M. C.
    Chadban, S.
    Chertow, G. M.
    De Nicola, L.
    Halimi, J. -M.
    Kanda, E.
    Li, G.
    Mennini, F. S.
    Navarro-Gonzalez, J. F.
    Power, A.
    Sultan, A. A.
    Webber, L.
    Wish, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 322 - 322
  • [38] Inside CKD: modelling the direct economic burden of concomitant chronic kidney disease and type 2 diabetes
    Power, A.
    Arnlov, J.
    Batista, M. C.
    Card-Gowers, J.
    Chadban, S.
    Chertow, G. M.
    De Nicola, L.
    Halimi, J. -M.
    Kanda, E.
    Li, G.
    Mennini, F. S.
    Navarro-Gonzalez, J. F.
    Sanchez, J. J. G.
    Tangri, N.
    Wish, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 322 - 323
  • [39] Inside CKD: Modeling the Direct Economic Burden of Concomitant Chronic Kidney Disease and Type 2 Diabetes
    Garcia Sanchez, Juan Jose
    Sultan, Alyshah Abdul
    Arnlov, Johan
    Batista, Marcelo C.
    Cabrera, Claudia
    Card-Gowers, Joshua
    Chadban, Steve
    Chertow, Glenn M.
    Denicola, Luca
    Halimi, Jean Michel
    Kanda, Eiichiro
    Li, Guisen
    Mennini, Francesco Saverio
    Navarro-Gonzalez, Juan
    Nolan, Stephen T.
    Power, Albert
    Retat, Lise
    Tangri, Navdeep
    Webber, Laura
    Wish, Jay
    Xu, Michael
    DIABETES, 2021, 70
  • [40] Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes
    Agarwal, Rajiv
    Ruilope, Luis M.
    Ruiz-Hurtado, Gema
    Haller, Hermann
    Schmieder, Roland E.
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Lambelet, Marc
    Nowack, Christina
    Kolkhof, Peter
    Joseph, Amer
    Bakris, George L.
    JOURNAL OF HYPERTENSION, 2023, 41 (02) : 295 - 302
12345